¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Gene amplification and analysis."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • modulator gene
    ÀÛµ¿À¯ÀüÀÚ, ¸Å°³À¯ÀüÀÚ
  • molecular check point gene
    ºÐÀڰ˹®À¯ÀüÀÚ
  • mutant gene
    µ¹¿¬º¯ÀÌÀ¯ÀüÀÚ
  • mutator gene
    º¯ÀÌÀ¯¹ßÀ¯ÀüÀÚ
  • marker gene
    Ç¥ÁöÀ¯ÀüÀÚ
  • nucleolar gene
    ÇÙ¼ÒüÀ¯ÀüÀÚ
  • one gene/one enzyme
    ÀÏÀ¯ÀüÀÚ/ÀÏÈ¿¼Ò¼³
  • operator gene
    ÀÛµ¿À¯ÀüÀÚ
  • recessive gene
    ¿­¼ºÀ¯ÀüÀÚ
  • regulator gene
    Á¶ÀýÀ¯ÀüÀÚ
  • regulatory gene
    Á¶ÀýÀ¯ÀüÀÚ
  • reporter gene
    Á¤º¸Á¦°øÀ¯ÀüÀÚ
  • repressor gene
    ¾ïÁ¦À¯ÀüÀÚ
  • retinoblastoma gene
    ¸Á¸·¸ð¼¼Æ÷Á¾À¯ÀüÀÚ
  • structural gene
    ±¸Á¶À¯ÀüÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • nucleolar gene
    ÇÙ¼ÒüÀ¯ÀüÀÚ
  • operator gene
    ÀÛµ¿À¯ÀüÀÚ
  • recessive gene
    ¿­¼ºÀ¯ÀüÀÚ
  • regulator gene
    Á¶ÀýÀ¯ÀüÀÚ
  • reporter gene
    Á¤º¸Á¦°øÀ¯ÀüÀÚ
  • repressor gene
    ¾ïÁ¦À¯ÀüÀÚ
  • retinoblastoma gene
    ¸Á¸·¸ð¼¼Æ÷Á¾À¯ÀüÀÚ
  • structural gene
    ±¸Á¶À¯ÀüÀÚ
  • suicide gene
    ÀÚ»ìÀ¯ÀüÀÚ
  • supressor gene
    ¾ïÁ¦À¯ÀüÀÚ
  • tumor suppressor gene
    Á¾¾ç¾ïÁ¦À¯ÀüÀÚ
  • single major gene locus model
    ´ÜÀÏÁÖ¿äÀ¯ÀüÀÚÀÚ¸®¸ðÇü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • recessive autosomal gene
    ¿­¼ºº¸Åë¿°»öüÀ¯ÀüÀÚ
  • recessive gene
    ¿­¼ºÀ¯ÀüÀÚ(¡­ë¶îîí­).
  • recessive gene
    ¿­¼ºÀ¯ÀüÀÚ
  • recessive gonosomal gene
    ¿­¼º¼º¿°»öüÀ¯ÀüÀÚ
  • recombination, gene
    À¯ÀüÀÚÀçÁ¶ÇÕ
  • regulator gene
    Á¶ÀýÀ¯ÀüÀÚ(ðàï½ë¶îîí­).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • complementary gene
    º¸Á·À¯ÀüÀÚ(ÜÍðëë¶îîí­), º¸Ã¼À¯ÀüÀÚ.
  • contiguous gene syndrome
    Á¢Ã˼º À¯ÀüÀÚ ÁõÈıº(ïÈõºàõë¶îîí­ñøý¦ÏØ)
  • contiguous gene syndrome
    ÀÎÁ¢ À¯ÀüÀÚ ÁõÈıº
  • control gene
    Á¦¾îÀ¯ÀüÀÚ(ð¤åÙë¶îîí­).
  • covering gene
    ÇǺ¹À¯ÀüÀÚ(¡­ë¶îîí­).
  • dcc gene
    DCC À¯ÀüÀÚ(¡­ë¶îîí­)
  • determinant gene
    °áÁ¤À¯ÀüÀÚ(̽ïÒë¶îîí­).
  • dominant autosomal gene
    ¿ì¼ºº¸Åë¿°»öüÀ¯ÀüÀÚ
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ(¡­ë¶îîí­).
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ(éÐàõë¶îîí­).
  • dq3.2 gene
    DQ3.2 À¯ÀüÀÚ(¡­ë¶îîí­)
  • duplicate gene
    º¹»çÀ¯ÀüÀÚ.
  • exaggeration gene
    °­Á¶À¯ÀüÀÚ(¡­ë¶îîí­).
  • familial colon carcinoma gene
    °¡Á·¼º ´ëÀå¾ÏÁ¾ À¯ÀüÀÚ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • morphogenetic gene
    ÇüÅÂÇü¼ºÀ¯ÀüÀÚ(û¡÷¾û¡à÷ë¶îîí­)
  • morphopoietic gene
    ÇüÅÂÀ¯ÀüÀÚ(û¡÷¾ë¶îîí­)
  • multiple gene
    ´ÙÀ¯ÀüÀÚ(Òýë¶îîí­)
  • mutable gene
    °¡º¯ÀÌÀ¯ÀüÀÚ(ʦܨì¶ë¶îîí­)
  • mutant gene
    º¯ÀÌÀ¯ÀüÀÚ(ܨì¶ë¶îîí­)
  • mutator gene
    º¯ÀÌÀÚ À¯ÀüÀÚ(ܨì¶í­ë¶îîí­)
  • negative gene control
    À½À¯ÀüÀÚÁ¦¾î(ëäë¶îîí­ð¤åÙ)
  • nif gene
    nif À¯ÀüÀÚ(ë¶îîí­)
  • nonessential gene
    ºñÇʼöÀ¯ÀüÀÚ(Þªù±áóë¶îîí­)
  • one-gene-one-enzyme hypothesis
    ÀÏÀ¯ÀüÀÚÀÏÈ¿¼Ò¼³(ìéë¶îîí­ìéý£áÈàã)
  • one-gene-one-polypeptide chain hypothesis
    ÀÏÀ¯ÀüÀÚ(ìéë¶îîí­) ÀÏ(ìé)Æú¸®ÆéŸÀÌµå »ç½½¼³(àã)
  • open gene
    ¿­¸° À¯ÀüÀÚ(ë¶îîí­)
  • operator gene
    ÀÛµ¿ÀÚÀ¯ÀüÀÚ(íÂÔÑí­ë¶îîí­)
  • overlapping gene
    Áßø(ñìôá) À¯ÀüÀÚ(ë¶îîí­)
  • PET gene
    PET À¯ÀüÀÚ(ë¶îîí­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
GTA gene transfer agent; Glanzmann thrombasthenia; glycerol teichoic acid
HGM hog gastric mucosa; human gene mapping; human glucose monitoring
HPR haptoglobin-related gene; health practices research
hsp heat shock protein [gene]
hut histidine utilization [gene]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
CFA Configural Frequency Analysis
CBA Cost Benefit Analysis
CEA Cost Effectiveness Analysis
CUA Cost Utility Analysis
DEA Data Envelopement Analysis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • separation of child and parents
    Áø·á ÁßÀÇ ¸ðÀÚ ºÐ¸®
  • signs and symptoms
    ¡ÈÄ¿Í Áõ»ó
  • spatial and temporal
    ½Ã°ø
  • subepithelial deposit and sclerosis
    »óÇÇÇÏ ÃàÀû°ú °æÈ­
  • superior and inferior lobe
    »ó ¹× ÇÏ¿±
  • supportive and symptomatic therapy
    Áõ»ó ¿ä¹ý
  • synovial bursae and sheaths
    À±È° ÁÖ¸Ó´Ï ¹× À±È°Áý
  • through-and-through drain
    °üÅë ¹è³ó°ü
  • to and fro absorbent system
    ¿Õº¹ Èí¼ö¹ý
  • to and fro flow
    ÀüÈÄ À¯µ¿
  • to and fro sound
    ¸¶ÂûÀ½
  • upright and relaxed position
    Á¤ÁÂÀ§ÀÇ ÀÌ¿ÏµÈ ÀÚ¼¼
  • wear and tear dermatitis
    ¹Ýº¹ ÀÚ±Ø ÇǺο°
  • wear and tear quota
    ¼Ò¸ðºÐ
  • wear-and-tear process
    ´â°í Âõ¾îÁö´Â °úÁ¤
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
gene expression regulation, developmental Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action during the developmental stages of an organism.
(12 Dec 1998)
gene expression regulation, enzymologic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis.
(12 Dec 1998)
gene expression regulation, fungal Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in fungi.
(12 Dec 1998)
gene expression regulation, leukaemic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in leukaemia.
(12 Dec 1998)
gene expression regulation, neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.
(12 Dec 1998)
gene expression regulation, plant Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in plants.
(12 Dec 1998)
gene expression regulation, viral Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses.
(12 Dec 1998)
gene families Groups of closely related genes that makesimilar products.
(09 Oct 1997)
gene family <molecular biology> A set of genes coding for diverse proteins which, by virtue of their high degree of sequence similarity, are believed to have evolved from a single ancestral gene. An example is the immunoglobulin family where the characteristic features of the constant domains are found in various cell surface receptors.
(18 Nov 1997)
gene flow The movement of genes from one population to another viainterbreeding.
(09 Oct 1997)
gene frequency The relative occurence (expressed as a percentage) of a gene in a given population.
(09 Oct 1997)
gene fusion Fusion of structural genes to analyze protein behaviour or fusion of regulatory sequences with structural genes to determine mechanisms of regulation.
(12 Dec 1998)
gene insertion The addition of one or more genesinto a genome from an externalsource.
(09 Oct 1997)
gene isolation A condition caused by a pair of alleles that, when present in the heterozygous form, inhibit the fertility of the organism that possessesthem.
(09 Oct 1997)
gene library <molecular biology> A collection of cloned DNA fragments that contains all the genetic information of a particular organism.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • in and in
    µ¿Á¾ ±³¹èÀÇ(·Î)
  • in and out
    (Áõ±ÇµîÀ» ´Ü±â·Î)¸Å¸ÅÇÏ´Â;(¹Ì¼Ó)µéÂß³¯ÂßÀÇ
  • in and outer
    (¹Ì¼Ó)(ÄÁµð¼ÇÀÌ)°í¸£Áö ¸øÇÑ ¼±¼ö(¿¬¿¹ÀÎ)
  • lares and penates
    Áý¾ÈÀÇ ¼öÈ£½Å;ÅÍÁÖ;°¡º¸;°¡Àç
  • make-and-break
    °³Æó½ÄÀÇ
  • mild and bitter
    ´Ü¸À ¾´¸ÀÀÌ ¹Ý¹ÝÀÎ ¸ÆÁÖ
  • milk and water
    ±èºüÁø;¸ß¾ø´Â;¸÷½Ã °¨»óÀûÀÎ
  • mix and match
    ±ÕÇüÀÌ ¸ÂÁö ¾Ê´Â °Í ³¢¸®ÀÇ Â¦Áö¿ò
  • nuts and bolts
    (±â°èÀÇ)ÀÛµ¿ºÎ(ºÐ);¿îÀü;°æ¿µ;(»ç¹°ÀÇ)±âº» ¿äÁ¡
  • park-and-ride
    Â÷·Î ¿ª±îÁö °¡¼­ ÁÖÂ÷Çϰí ÀüÂ÷³ª ¹ö½º·Î °¥¾ÆÅ¸´Â (¹æ½Ä)
  • quick and dirty
    (Ä«¿îÅͽÄÀÇ)°£ÀÌ ½Ä´ç(snack bar)
  • rag-and-none man
    ³Õ¸¶ÁÖÀÌ
  • rank-and-file
    Æò»ç¿øÀÇ;(ÁöµµÀÚ°¡ ¾Æ´Ñ)ÀÏ¹Ý Á¶ÇÕ¿øÀÇ;¼­¹Î.ÀÏ¹Ý ´ëÁßÀÇ;(Àå±³°¡ ¾Æ´Ñ)»çº´ÀÇ
  • rank-and-filer
    »çº´;ÀϹݽùÎ;¼­¹Î;Æò»ç¿øµé;Æò´ç¿øµé
  • reach and frequency
    µµ´Þµµ¿Í µµ´Þ Ƚ¼ö(ÀÏ·ÃÀÇ ±¤°í Ȱµ¿À¸·Î ±× °­°í°¡ ¾î´À Á¤µµ ħÅõ Çߴ°¡¸¦ ÃøÁ¤ÇÒ ¶§ »ç¿ëµÇ´Â µÎ°¡Áö ¿ä¼Ò)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á